Company announced the consolidation of all non-U.S. businesses into Sterling International. Five VPs wiil take on worldwide staff responsibilities in business development, finance, scientific affairs, personnel and manufacturing. Line management will be structured under four geographically oriented groups: Europe; Japan, Canada and Australasia/Pacific; Latin America; Middle East, Africa and sub-continent. John McCarthy has been named Senior VP of Sterling International, and will serve as deputy to Sterling Drug President James Andress.
You may also be interested in...
The US FDA and NIST have agreed to help industry modernize and update pharmaceutical manufacturing methods and to improve supply chain resilience.
Medtronic is sponsoring a trial to evaluate its adaptive deep brain stimulation technology, a unique feature of the Percept PC device for treating Parkinson’s disease.
The company cited lackluster efficacy in its decision to discontinue development of V590 and V591. It will instead develop two drugs to treat COVID-19.